Int J Oral Maxillofac Implants. 2022 Jul-Aug;37(4):771-777. doi: 10.11607/jomi.9301.
Acceleration of the bone healing period and/or increasing the quality of newly formed bone still have great importance in the field of oral and maxillofacial surgery. The aim of this study was to evaluate the effect of isolated liquid Mecsina (herbal extract) and its combination with xenogeneic graft material (bovine bone graft) on bone regeneration.
Full-thickness critical-size defects with 10-mm diameter and 2-mm depth were created on the calvarial bone region in 28 Sprague Dawley male rats. Four groups were generated: Mecsina Hemostopper, Mecsina Hemostopper + graft group, only graft group, and empty control group. On the 28th day following surgery, all animals were sacrificed. The calvarial samples were evaluated both histopathologically and histomorphometrically.
According to the histopathologic evaluation result, vascular proliferation was significantly higher in the groups in which Mecsina Hemostopper was used as a single material or in combination with graft material (P < .05). Histomorphometric evaluation showed that trabecular and osteoid thickness were significantly higher in all Mecsina application groups (P < .05).
Mecsina Hemostopper was found to be an effective agent in increasing cell proliferation and providing more qualified bone formation. The combination of Mecsina and xenogeneic bone graft was found to be one of the most effective augmentation options for critical-size defects in rats. Mecsina Hemostopper could be used to get more qualified bone formation clinically, but more clinical research is needed in the future.
在口腔颌面外科学领域,加速骨愈合期和/或提高新形成骨的质量仍然具有重要意义。本研究旨在评估单独使用液体 Mecsina(草药提取物)及其与异种移植物材料(牛骨移植物)组合对骨再生的影响。
在 28 只雄性 Sprague Dawley 大鼠的颅骨区域创建全厚临界尺寸缺陷,直径为 10mm,深度为 2mm。生成了 4 个组:Mecsina Hemostopper、Mecsina Hemostopper+移植物组、仅移植物组和空对照组。手术后第 28 天,所有动物均被处死。对颅骨样本进行组织病理学和组织形态计量学评估。
根据组织病理学评估结果,单独使用 Mecsina Hemostopper 或与移植物材料联合使用时,血管增殖明显更高(P<.05)。组织形态计量学评估显示,所有 Mecsina 应用组的小梁和类骨质厚度均显著更高(P<.05)。
Mecsina Hemostopper 被发现是一种有效的促进细胞增殖和提供更优质骨形成的药物。Mecsina 与异种骨移植物的联合使用被发现是大鼠临界尺寸缺陷最有效的增强选择之一。Mecsina Hemostopper 可在临床上获得更优质的骨形成,但未来需要更多的临床研究。